Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 3.73
-0.267 %
$ 491 M
Market Cap
-0.73
P/E
CASH FLOW STATEMENT
-282 M
OPERATING CASH FLOW
242 M
INVESTING CASH FLOW
-465 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Canopy Growth Corporation
| Net Income | -484 M |
| Depreciation & Amortization | 53.2 M |
| Capital Expenditures | -4 M |
| Stock-Based Compensation | 14.2 M |
| Change in Working Capital | 0 |
| Others | 122 M |
| Free Cash Flow | -286 M |
Cash Flow
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | Dec-2014 | Dec-2013 | Jul-2013 | Jul-2012 | Jul-2011 | Jul-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||
| Net Income | (483.7) | (3 309.5) | (320.5) | (1 670.8) | (1 387.4) | (670.1) | (54.1) | (16.7) | (3.5) | (8.9) | (0.9) | 64.6 K | 21.4 K | 24.1 K | 26.9 K |
| Depreciation & Amortization | 53.2 | 84.5 | 114.4 | 127.1 | 125.0 | 46.9 | 20.5 | 6.1 | 2.3 | 0.4 | 4.19 K | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 12.3 | (4.8) | (8.9) | (13.1) | (121.6) | 12.3 | 1.6 | (0.4) | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 14.2 | 25.3 | 46.7 | 91.1 | 320.3 | 287.8 | 51.2 | 10.0 | 3.7 | 2.2 | 0.2 | 25.4 K | 0 | 0 | 12.6 K |
| Other Operating Activities | 122.0 | 2 575.2 | (543.9) | 1 004.3 | 494.9 | 64.7 | (72.1) | (22.1) | (37.7) | 1.0 | 70.6 K | 536 | 0 | 0 | 0 |
| Change in Working Capital | 0 | 65.8 | 165.6 | (4.3) | (203.8) | (262.2) | (28.5) | (4.1) | 22.7 | (4.4) | (0.7) | 1.66 K | 2.74 K | 4.34 K | 7.32 K |
| Cash From Operations | (281.9) | (557.5) | (545.8) | (465.7) | (772.6) | (520.5) | (81.5) | (27.1) | (12.4) | (9.7) | (1.4) | 37 K | 18.7 K | 28.4 K | 7 K |
| INVESTING CASH FLOW | |||||||||||||||
| Capital Expenditures | (4.0) | (10.6) | (48.1) | (174.1) | (721.9) | (682.7) | (178.2) | (29.5) | (10.7) | (12.0) | (1.1) | 0 | 0 | 0 | 0 |
| Other Items | 245.6 | 443.9 | 278.9 | (710.0) | 374.2 | (2 545.2) | (45.4) | 10.9 | (1.6) | 0 | 10 K | 25.3 K | 30 K | 0 | (0.6) |
| Cash From Investing Activities | 241.6 | 433.4 | 230.8 | (884.1) | (347.7) | (3 228.0) | (223.6) | (18.6) | (12.3) | (12.0) | (1.1) | 25.3 K | 30 K | 0 | (0.6) |
| FINANCING CASH FLOW | |||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (509.8) | 17.0 | (50.8) | 877.5 | (100.2) | 595.3 | (1.5) | 2.8 | (1.9) | 1.8 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (36.3) | (37.7) | 2.5 | 387.2 | 43.0 | 14.4 | 1.8 | (1.0) | 6.4 | (0.4) | (0.4) | 0 | 1 K | 0 | (0.1) |
| Cash From Financing Activities | (465.1) | (19.7) | (45.5) | 1 264.8 | (57.2) | 5 837.2 | 525.8 | 132.1 | 18.7 | 25.4 | 4.5 | 0 | 1 K | 0 | 0.6 |
| CHANGE IN CASH | |||||||||||||||
| Net Change In Cash | (506.7) | (99.0) | (378.6) | (148.5) | (1 177.7) | 2 158.3 | 220.8 | 86.4 | (6.0) | 3.7 | 2.1 | 11.7 K | 12.3 K | 28.4 K | 38 K |
| FREE CASH FLOW | |||||||||||||||
| Free Cash Flow | (285.9) | (568.1) | (593.9) | (639.9) | (1 494.5) | (1 203.3) | (259.7) | (56.6) | (23.2) | (21.7) | (2.4) | 37 K | 18.7 K | 28.4 K | 7 K |